Tuvutromstat is an orally bioavailable inhibitor of MAT2A, a metabolic enzyme that produces S-adenosyl-L-methionine, the primary methyl donor for cellular transmethylation. It is being studied in solid tumors, particularly MTAP-deleted cancers that depend heavily on SAM synthesis.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as
IDE-397, GSK-4362676
Drug type
Small molecule
Targets
methionine adenosyltransferase II alpha (MAT2A)
Mechanism
Inhibitor of methionine adenosyltransferase II alpha (MAT2A)
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.